MetaCap

Climb Bio (CLYM) Stock Chart

NASDAQ: CLYMHealthcareBiotechnologyUSD

10.71+0.03 (+0.28%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

CLYM technical summary

CLYM is trading 23.3% below its 50-day simple moving average of $13.96 and 8.5% above its 200-day average of $9.87. The 50-day average is above the 200-day average, a configuration technical analysts associate with a longer-term uptrend. The 14-day Relative Strength Index (RSI) is 30.0, below 30, the level many traders consider oversold.

Over the past year, the stock ranged from $1.54 (Oct 7, 2025) to $18.33 (Aug 25, 2026); the current price sits 55% of the way from the low to the high. Annualized 30-day volatility is 69.4%. Based on the last session's high, low and close, the classic pivot point is $10.67, with first resistance at $10.99 and first support at $10.39.

These indicators describe past price behavior for Climb Bio; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
18.33 (Aug 25)
1Y low
1.54 (Oct 7)
Last close
10.71

CLYM price performance

1 week

-6.63%

1 month

-32.64%

3 months

-21.08%

6 months

+50.85%

Year to date

+167.75%

1 year

+549.09%

3 years

+310.34%

5 years

-33.64%

CLYM price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day10.89Price below10.95Price below
10-day11.27Price below11.45Price below
20-day12.65Price below12.34Price below
50-day13.96Price below13.16Price below
100-day12.99Price below12.44Price below
200-day9.87Price above9.64Price above

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)11.60
Resistance 2 (R2)11.27
Resistance 1 (R1)10.99
Pivot point10.67
Support 1 (S1)10.39
Support 2 (S2)10.06
Support 3 (S3)9.78

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis